<DOC>
	<DOCNO>NCT01694459</DOCNO>
	<brief_summary>International guideline support use full-dose heparin ( anticoagulant ) coronary intervention . However , low dose heparin may adequate , thanks advance angioplasty technique widespread use pretreatment two antiplatelet agent . Thus investigator design study compare safety efficacy standard dose heparin ( 100 UI/Kg ) versus low-dose ( 50 UI/Kg ) patient undergo coronary angioplasty aspirin clopidogrel time procedure .</brief_summary>
	<brief_title>DEDICA ( Dose HEparin During Coronary Angioplasty ) Trial</brief_title>
	<detailed_description>- Patients undergo coronary angioplasty randomise standard vs. low-dose heparin . study include `` all-comers '' ( patient either stable angina acute coronary syndrome ) ; patient ST-elevation myocardial infarction exclude . - An ACT ( activate clotting time ) perform initial bolus heparin : standard dose group target ACT &gt; 300 sec . ( recommended guideline ) low-dose target ACT &gt; 180 sec . Aim study show equivalence ischemic event two dos heparin , order confirm safety lower dose heparin contemporary coronary intervention .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Angina Pectoris</mesh_term>
	<mesh_term>Angina , Stable</mesh_term>
	<mesh_term>Angina , Unstable</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>Stable angina , unstable angina NonST elevation myocardial infarction undergo coronary angioplasty . Mandatory pretreatment aspirin clopidogrel ST elevation myocardial infarction Coronary intervention rotational atherectomy Coronary intervention chronic total occlusion ( CTO )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>angioplasty</keyword>
	<keyword>heparin</keyword>
	<keyword>trial</keyword>
</DOC>